Literature DB >> 20886225

Phenotype and growth behavior of residual β-catenin-positive hepatocytes in livers of β-catenin-deficient mice.

Albert Braeuning1, Yasmin Singh, Benjamin Rignall, Albrecht Buchmann, Seddik Hammad, Amnah Othman, Iris von Recklinghausen, Patricio Godoy, Stefan Hoehme, Dirk Drasdo, Jan G Hengstler, Michael Schwarz.   

Abstract

Signaling through the Wnt/β-catenin pathway is a crucial determinant of hepatic zonal gene expression, liver development, regeneration, and tumorigenesis. Transgenic mice with hepatocyte-specific knockout of Ctnnb1 (encoding β-catenin) have proven their usefulness in elucidating these processes. We now found that a small number of hepatocytes escape the Cre-mediated gene knockout in that mouse model. The remaining β-catenin-positive hepatocytes showed approximately 25% higher cell volumes compared to the β-catenin-negative cells and exhibited a marker protein expression profile similar to that of normal perivenous hepatocytes or hepatoma cells with mutationally activated β-catenin. Surprisingly, the expression pattern was observed independent of the cell's position within the liver lobule, suggesting a malfunction of physiological periportal repression of perivenously expressed genes in β-catenin-deficient liver. Clusters of β-catenin-expressing hepatocytes lacked expression of the gap junction proteins Connexin 26 and 32. Nonetheless, β-catenin-positive hepatocytes had no striking proliferative advantage, but started to grow out on treatment with phenobarbital, a tumor-promoting agent known to facilitate the formation of mouse liver adenoma with activating mutations of Ctnnb1. Progressive re-population of Ctnnb1 knockout livers with wild-type hepatocytes was seen in aged mice with a pre-cirrhotic phenotype. In these large clusters of β-catenin-expressing hepatocytes, perivenous-specific gene expression was re-established. In summary, our data demonstrate that the zone-specificity of a hepatocyte's gene expression profile is dependent on the presence of β-catenin, and that β-catenin provides a proliferative advantage to hepatocytes when promoted with phenobarbital, or in a pre-cirrhotic environment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20886225     DOI: 10.1007/s00418-010-0747-1

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  49 in total

Review 1.  Functional specialization of different hepatocyte populations.

Authors:  K Jungermann; N Katz
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

Review 2.  WNT/beta-catenin signaling in liver health and disease.

Authors:  Michael D Thompson; Satdarshan P S Monga
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

3.  Reestablishment of the heterogeneous distribution of hepatic glutamine synthetase during regeneration after CCl4-intoxication.

Authors:  L Schöls; D Mecke; R Gebhardt
Journal:  Histochemistry       Date:  1990

4.  Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.

Authors:  Stefanie Giera; Albert Braeuning; Christoph Köhle; Wilfried Bursch; Ute Metzger; Albrecht Buchmann; Michael Schwarz
Journal:  Toxicol Sci       Date:  2010-01-30       Impact factor: 4.849

Review 5.  Beta-catenin: a key mediator of Wnt signaling.

Authors:  K Willert; R Nusse
Journal:  Curr Opin Genet Dev       Date:  1998-02       Impact factor: 5.578

6.  Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.

Authors:  Albert Braeuning; Riccardo Sanna; Joerg Huelsken; Michael Schwarz
Journal:  Drug Metab Dispos       Date:  2009-02-23       Impact factor: 3.922

7.  Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.

Authors:  Yuichi Nakashima; Takashi Ono; Akira Yamanoi; Osama Nazmy El-Assal; Hitoshi Kohno; Naofumi Nagasue
Journal:  J Gastroenterol       Date:  2004-08       Impact factor: 7.527

8.  Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis.

Authors:  Patricio Godoy; Jan G Hengstler; Iryna Ilkavets; Christoph Meyer; Anastasia Bachmann; Alexandra Müller; Gregor Tuschl; Stefan O Mueller; Steven Dooley
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

9.  Zonal gene expression in murine liver: lessons from tumors.

Authors:  Stephan Hailfinger; Maike Jaworski; Albert Braeuning; Albrecht Buchmann; Michael Schwarz
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

Review 10.  beta-Catenin as a multilayer modulator of zonal cytochrome P450 expression in mouse liver.

Authors:  Albert Braeuning; Michael Schwarz
Journal:  Biol Chem       Date:  2010 Feb-Mar       Impact factor: 3.915

View more
  18 in total

Review 1.  Histochemistry and cell biology: the annual review 2010.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2011-01-29       Impact factor: 4.304

2.  Spontaneous repopulation of β-catenin null livers with β-catenin-positive hepatocytes after chronic murine liver injury.

Authors:  Michael D Thompson; Emily D Wickline; William B Bowen; Amy Lu; Sucha Singh; Amalea Misse; Satdarshan P S Monga
Journal:  Hepatology       Date:  2011-07-21       Impact factor: 17.425

3.  Hepatocyte γ-catenin compensates for conditionally deleted β-catenin at adherens junctions.

Authors:  Emily Diane Wickline; Prince Kwaku Awuah; Jaideep Behari; Mark Ross; Donna B Stolz; Satdarshan P S Monga
Journal:  J Hepatol       Date:  2011-04-13       Impact factor: 25.083

Review 4.  Postnatal development, maturation and aging in the mouse cochlea and their effects on hair cell regeneration.

Authors:  Bradley J Walters; Jian Zuo
Journal:  Hear Res       Date:  2012-11-16       Impact factor: 3.208

5.  Phenotype of single hepatocytes expressing an activated version of β-catenin in liver of transgenic mice.

Authors:  Sandra Schreiber; Benjamin Rignall; Albert Braeuning; Philip Marx-Stoelting; Thomas Ott; Albrecht Buchmann; Seddik Hammad; Jan G Hengstler; Michael Schwarz; Christoph Köhle
Journal:  J Mol Histol       Date:  2011-08-06       Impact factor: 2.611

6.  Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development.

Authors:  Er-Yea Wang; Shiou-Hwei Yeh; Ting-Fen Tsai; Hsiang-Po Huang; Yung-Ming Jeng; Wei-Hsiang Lin; Wei-Chih Chen; Kun-Huei Yeh; Pei-Jer Chen; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

7.  Pericentral activity of alpha-fetoprotein enhancer 3 and glutamine synthetase upstream enhancer in the adult liver are regulated by β-catenin in mice.

Authors:  Erica L Clinkenbeard; James E Butler; Brett T Spear
Journal:  Hepatology       Date:  2012-11       Impact factor: 17.425

8.  A novel role of nucleostemin in maintaining the genome integrity of dividing hepatocytes during mouse liver development and regeneration.

Authors:  Tao Lin; Wessam Ibrahim; Cheng-Yuan Peng; Milton J Finegold; Robert Y L Tsai
Journal:  Hepatology       Date:  2013-10-21       Impact factor: 17.425

9.  Amniotic mesenchymal stem cells derived hepatocyte-like cells attenuated liver fibrosis more efficiently by mixed-cell transplantation.

Authors:  Hui Wang; Yuan Tian; Xin Li; Meijia Yang; Ying Yan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-02-25

Review 10.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.